tirzepatide surpass-5 Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Efficacy of tirzepatide 5, 10
Description
The best thing you can do is have a conversation with a healthcare provider

Recognizing the signs that warrant professional help can make all the difference

Choose an injection site on your abdomen (lower stomach), upper arm, or thigh

Tirzepatide's Role in Weight Loss and Metabolic Fertility Factors Tirzepatide activates GLP-1 and GIP receptors in the brain and pancreas, suppressing appetite and enhancing insulin secretion in response to meals
00187-5/asset/eb17eccf-07a4-45a3-a12d-9267d643bc9d/main.assets/gr2_lrg.jpg)
While this doesn't directly cause weight gain, it may alter the effectiveness of other treatments
Avoid screens 60 minutes before bed
